Group structure
30 companies in 21 countries
Loadingโฆ
30 companies in 21 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 254
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABREVA10% ยท Cream | Docosanol | United States | Marketed | 2000 |
| ADVIL200mg base ยท Tablet | Ibuprofen | United States | Marketed | 2012 |
| ADVIL200mg ยท Tablet | Ibuprofen | United States | Marketed | 1984 |
| ADVIL 12 HOUR600 mg ยท Tablet (Extended-Release) | Ibuprofen | Canada | Marketed | 2016 |
| ADVIL ALLERGY AND CONGESTION RELIEF4mg; 200mg; 10mg ยท Tablet | Chlorpheniramine, Ibuprofen, Phenylephrine | United States | Marketed | 2011 |
| ADVIL ALLERGY SINUS2mg; 200mg; 30mg ยท Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | United States | Marketed | 2002 |
| ADVIL ARTHRITIS PAIN400 mg ยท Capsule | Ibuprofen | Canada | Marketed | 2014 |
| ADVIL BACK PAIN200 mg + 500 mg ยท Tablet | Ibuprofen, Methocarbamol | Canada | Authorised | |
| ADVIL CAPLETS200 mg ยท Tablet | Ibuprofen | Canada | Marketed | 1992 |
| ADVIL COLD AND SINUS200mg free acid and potassium salt; 30mg ยท Capsule | Ibuprofen, Salt, Pseudoephedrine | United States | Marketed | 2002 |
| ADVIL COLD AND SINUS200mg; 30mg ยท Tablet | Ibuprofen, Pseudoephedrine | United States | Marketed | 1989 |
| ADVIL COLD AND SINUS200 mg + 30 mg ยท Tablet | Ibuprofen, Pseudoephedrine | Canada | Marketed | 1993 |
| ADVIL COLD AND SINUS DAYTIME200 mg + 30 mg ยท Tablet | Ibuprofen, Pseudoephedrine | Canada | Marketed | 2006 |
| ADVIL COLD AND SINUS NIGHTTIME2 mg + 200 mg + 30 mg ยท Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2006 |
| ADVIL COLD & SINUS CONVENIENCE PACK2 mg + 200 mg + 200 mg + 30 mg + 30 mg ยท Kit, Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2014 |
| ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS400 mg + 60 mg ยท Capsule | Ibuprofen, Pseudoephedrine | Canada | Authorised | |
| ADVIL COLD, SINUS & FLU EXTRA STRENGTH4 mg + 400 mg + 60 mg ยท Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2018 |
| ADVIL COLD & SINUS LIQUI-GELS200 mg + 30 mg ยท Capsule | Ibuprofen, Pseudoephedrine | Canada | Marketed | 2005 |
| ADVIL COLD & SINUS PLUS2 mg + 200 mg + 30 mg ยท Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2004 |
| ADVIL CONGESTION RELIEF200mg; 10mg ยท Tablet | Ibuprofen, Phenylephrine | United States | Marketed | 2010 |
| Advil, dragees 200 mgOmhulde tablet | Ibuprofen | Netherlands | Authorised | 1987 |
| ADVIL DUAL ACTION WITH ACETAMINOPHEN250mg; 125mg ยท Tablet | Paracetamol, Ibuprofen | United States | Marketed | 2020 |
| ADVIL EXTRA STRENGTH CAPLETS400 mg ยท Tablet | Ibuprofen | Canada | Marketed | 2002 |
| ADVIL EXTRA STRENGTH LIQUI-GELS400 mg ยท Capsule | Ibuprofen | Canada | Marketed | 2004 |
| ADVIL FLU25 mg + 200 mg ยท Capsule | Diphenhydramine, Ibuprofen | Canada | Marketed | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 106 | 101 | 5 | CompaniesAll medicines |
| Netherlands | 35 | 35 | 0 | CompaniesAll medicines |
| United States | 33 | 33 | 0 | CompaniesAll medicines |
| Spain | 32 | 27 | 5 | CompaniesAll medicines |
| Singapore | 29 | 29 | 0 | CompaniesAll medicines |
| Croatia | 17 | 17 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, France, Italy, Malaysia, Serbia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brรธnnรธysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence: Norwegian Licence for Open Government Data
Oficiul Naศional al Registrului Comerศului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Register prรกvnickรฝch osรดb, podnikateฤพov a orgรกnov verejnej moci; public API licence names ล tatistickรฝ รบrad Slovenskej republiky; administration transferred to Ministerstvo vnรบtra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence: Creative Commons Attribution
Slovak Ministry of Finance, Register รบฤtovnรฝch zรกvierok (RรZ) Open API; exact IฤO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence: CC0
Report an error or request removalCorrections from the company itself are welcome.
Keep Haleonโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.